Skip to main content

Table 6 Risk factors of VRE among HIV positive and HIV negative clients at Gondar University Teaching Hospital, Northwest Ethiopia, 2013

From: Prevalence of vancomycin resistant Enterococci and associated risk factors among clients with and without HIV in Northwest Ethiopia: a cross-sectional study

Risk factors

Enterococci

Total Number (%)

P-value

AOR (95% CI)

VRE

VSE

Number (%)

Number (%)

Antibiotic treatment (>2 weeks)

     

Yes

10 (9.6)

94 (90.4)

104 (51.7)

0.01

10.21 (1.31 – 217.40)

No

1 (1.0)

96 (99.0)

97 (48.3)

---

1.00

CD4 *

     

≤350

5 (11.4)

39 (88.6)

44 (42.7)

0.21

2.39 (0.46 – 13.57)

>350

3 (5.1)

56 (94.9)

59 (57.3)

---

1.00

HAART

     

Yes*

8 (7.8)

94 (92.2)

102 (50.7)

0.13

2.72 (0.63 – 13.40)

No

3 (3.0)

96 (97.0)

99 (49.3)

---

1.00

HAART Duration (Year)*

     

≤2

2 (6.7)

28 (93.3)

30 (29.1)

---

1.00

>2

6 (8.2)

67 (91.8)

73 (70.9)

0.57

1.25 (0.21 – 9.62)

WBC counts

     

Normal

11 (6.6)

156 (93.4)

167 (83.1)

---

1.00

Leucopenic

0 (0)

27 (100)

27 (13.4)

0.18

0.00 (0.00 – 2.92)

Leucocytosis

0 (0)

7 (100)

7 (3.5)

0.62

0.00 (0.00 – 12.95)

Platelet

     

Normal

10 (5.6)

168 (94.4)

188 (88.6)

---

1.00

Thrombocytopenic

0 (0)

12 (100)

12 (6.0)

0.51

0.00 (0.00 – 8.40)

Thrombocytosis

1 (9.1)

10 (90.9)

11 (5.4)

0.49

1.68 (NA)

Nutritional status

     

Normal

8 (4.7)

161 (95.3)

169 (84.1)

---

1.00

Malnourished

2 (13.3)

13 (86.7)

15 (7.5)

0.19

3.10 (0.41 – 18.57)

Overweight

1 (5.9)

16 (94.1)

17 (8.5)

0.59

1.26 (NA)

Anemic

     

Yes

11 (5.8)

179 (94.2)

190 (94.5)

0.52

UD

No

0 (0)

11 (100)

11 (5.5)

---

1.00

Drinking alcohol

     

Yes

2 (3.4)

57 (96.6)

59 (29.4)

0.32

0.52 (0.07 – 2.69)

No

9 (6.3)

133 (93.7)

142 (70.6)

---

1.00

WHO stage*

     

I

2 (8.3)

22 (91.7)

24 (23.3)

---

1.00

II

0 (0)

15 (100)

15 (14.6)

0.37

0.00 (0.00 – 6.91)

III

2 (6.7)

28 (93.3)

30 (29.1)

0.60

0.79 (0.07 – 8.68)

IV

4 (11.8)

30 (88.2)

34 (33.3)

0.51

1.470.20 – 12.82)

  1. *Only for HIV infected patients.